年別の研究成果
年別の研究成果
検索結果
-
2022
Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
Ishii, M., Akao, M., Yasuda, S., Kaikita, K., Ako, J., Matoba, T., Nakamura, M., Miyauchi, K., Hagiwara, N., Kimura, K., Hirayama, A., Matsui, K. & Ogawa, H., 2022, In: Journal of the American Heart Association. 11, 21, e027107.研究成果: ジャーナルへの寄稿 › レター › 査読
Open Access -
2021
Clinical outcomes of rivaroxaban monotherapy in heart failure patients with atrial fibrillation and stable coronary disease: Insights from the AFIRE trial
Yazaki, Y., Nakamura, M., Iijima, R., Yasuda, S., Kaikita, K., Akao, M., Ako, J., Matoba, T., Miyauchi, K., Hagiwara, N., Kimura, K., Hirayama, A., Matsui, K. & Ogawa, H., 2021, (印刷中) In: Circulation. p. 1449-1451 3 p.研究成果: ジャーナルへの寄稿 › レター › 査読
2 被引用数 (Scopus) -
2017
Response by takase and matoba to letter regarding article, "ezetimibe in combination with statins ameliorates endothelial dysfunction in coronary arteries after stenting: The cuvic trial (effect of cholesterol absorption inhibitor usage on target vessel dysfunction after coronary stenting), a multicenter randomized controlled trial"
Takase, S. & Matoba, T., 5月 1 2017, In: Arteriosclerosis, thrombosis, and vascular biology. 37, 5, p. e54研究成果: ジャーナルへの寄稿 › レター › 査読
1 被引用数 (Scopus)